JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
Janus Henderson Short Duration Income ETF
VNLA
$3.44B
| $2.09M | ﹤0.01% |
43,108
+7,409
| +21% | +$359K |
2023 Q1
5 quarters
|
|
3602
AdvanSix
ASIX
$438M
| $2.09M | ﹤0.01% |
91,268
-12,410
| -12% | -$309K |
2016 Q4
30 quarters
|
|
3603
FTAI Infrastructure
FIP
$318M
| $2.09M | ﹤0.01% |
242,391
+41,668
| +21% | +$318K |
2023 Q2
4 quarters
|
|
3604
AMC Global Media
AMCX
$460M
| $2.09M | ﹤0.01% |
216,052
-28,110
| -12% | -$371K |
2013 Q2
44 quarters
|
|
3605
PUT
Biogen
BIIB
$32.5B
| $2.09M | ﹤0.01% |
9,000
| – | – |
2020 Q4
14 quarters
|
|
3606
Celldex Therapeutics
CLDX
$2.49B
| $2.09M | ﹤0.01% |
56,364
+9,609
| +21% | +$363K |
2017 Q4
26 quarters
|
|
3607
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$126M
| $2.08M | ﹤0.01% |
47,564
+12,728
| +37% | +$634K |
2021 Q2
12 quarters
|
|
|
OSG
3608
Octave Specialty Group
OSG
$207M
| $2.08M | ﹤0.01% |
161,972
+20,848
| +15% | +$318K |
2013 Q2
44 quarters
|
|
3609
PUT
Marvell Technology
MRVL
$245B
| $2.08M | ﹤0.01% |
29,700
-46,100
| -61% | -$3.23M |
2023 Q4
2 quarters
|
|
3610
indie Semiconductor
INDI
$688M
| $2.07M | ﹤0.01% |
335,618
+9,606
| +3% | +$61.1K |
2021 Q4
10 quarters
|
|
3611
Eagle Bancorp
EGBN
$865M
| $2.07M | ﹤0.01% |
109,505
-60,157
| -35% | -$1.17M |
2017 Q4
26 quarters
|
|
3612
Peloton Interactive
PTON
$2.16B
| $2.06M | ﹤0.01% |
610,898
+180,969
| +42% | +$648K |
2019 Q3
19 quarters
|
|
3613
Cheesecake Factory
CAKE
$5.46B
| $2.06M | ﹤0.01% |
52,554
-3,373
| -6% | -$125K |
2013 Q2
44 quarters
|
|
3614
Schwab Municipal Bond ETF
SCMB
$3.22B
| $2.06M | ﹤0.01% |
80,282
+72,104
| +882% | +$1.86M |
2023 Q3
3 quarters
|
|
3615
CALL
Nutrien
NTR
$33.4B
| $2.06M | ﹤0.01% |
40,400
-1,100
| -3% | -$60.2K |
2023 Q3
3 quarters
|
|
3616
Enanta Pharmaceuticals
ENTA
$377M
| $2.06M | ﹤0.01% |
158,546
+20,499
| +15% | +$277K |
2016 Q1
33 quarters
|
|
|
TSVT
3617
DELISTED
2seventy bio
TSVT
| $2.05M | ﹤0.01% |
532,432
-431,280
| -45% | -$1.94M |
2021 Q4
10 quarters
|
|
3618
The RealReal
REAL
$1.08B
| $2.04M | ﹤0.01% |
640,919
+78,304
| +14% | +$289K |
2019 Q2
20 quarters
|
|
3619
CALL
Lucid Motors
LCID
$1.63B
| $2.04M | ﹤0.01% |
78,290
-88,870
| -53% | -$2.37M |
2023 Q4
2 quarters
|
|
3620
MacroGenics
MGNX
$228M
| $2.04M | ﹤0.01% |
480,261
-548,788
| -53% | -$5.34M |
2013 Q4
42 quarters
|
|
3621
Credit Acceptance
CACC
$5.48B
| $2.04M | ﹤0.01% |
3,964
-15,689
| -80% | -$7.99M |
2013 Q2
44 quarters
|
|
3622
Innovator US Equity Power Buffer ETF January
PJAN
$1.43B
| $2.04M | ﹤0.01% |
50,632
+27,117
| +115% | +$1.07M |
2024 Q1
1 quarter
|
|
3623
Vanguard Russell 2000 Growth ETF
VTWG
$1.44B
| $2.04M | ﹤0.01% |
10,658
-330
| -3% | -$62.3K |
2021 Q1
13 quarters
|
|
3624
Universal Insurance Holdings
UVE
$1.22B
| $2.04M | ﹤0.01% |
108,482
+25,416
| +31% | +$494K |
2015 Q1
37 quarters
|
|
3625
Zentalis Pharmaceuticals
ZNTL
$239M
| $2.03M | ﹤0.01% |
495,810
+437,189
| +746% | +$4.88M |
2020 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.